US 8816077
Oligomer-protein tyrosine kinase inhibitor conjugates
granted A61KA61K31/541A61K47/60
Quick answer
US patent 8816077 (Oligomer-protein tyrosine kinase inhibitor conjugates) held by Nektar Therapeutics expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/541, A61K47/60, A61P, A61P35/00